Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2004-09-29
2010-10-12
Chen, Shin-Lin (Department: 1632)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S350000
Reexamination Certificate
active
07811981
ABSTRACT:
A method of preventing, inhibiting and/or reversing cell motility, actin filament assembly or disassembly, proliferation, colonization, differentiation, accumulation and/or development of abnormal cells in a subject is disclosed. The method is effected by administering to the subject a therapeutically effective amount of a ribonuclease of the T2 family having actin binding activity.
REFERENCES:
patent: 3791932 (1974-02-01), Schuurs et al.
patent: 3839153 (1974-10-01), Schuurs et al.
patent: 3850578 (1974-11-01), McConnell
patent: 3850752 (1974-11-01), Schuurs et al.
patent: 3853987 (1974-12-01), Dreyer
patent: 3867517 (1975-02-01), Ling
patent: 3879262 (1975-04-01), Schuurs et al.
patent: 3901654 (1975-08-01), Gross
patent: 3935074 (1976-01-01), Rubenstein et al.
patent: 3984533 (1976-10-01), Uzgiris
patent: 3996345 (1976-12-01), Ullman et al.
patent: 4034074 (1977-07-01), Miles
patent: 4098876 (1978-07-01), Piasio et al.
patent: 4879219 (1989-11-01), Wands et al.
patent: 5011771 (1991-04-01), Bellet et al.
patent: 5281521 (1994-01-01), Trojanowski et al.
patent: 5786457 (1998-07-01), Nett et al.
Ide et al., 1991, FEBS Letters, vol. 284, No. 2, p. 161-164.
Zhu et al., 1990, Journal of Bacteriology, vol. 172, p. 3146-3151.
Ye et al., 1996, Plant Molecular Biology, vol. 30, p. 697-709.
Irie et al., 1997, Journal of Biochemistry, vol. 121, p. 849-853.
Gura, T., 1997, Science, Vo. 278, p. 1041-1042.
Orkin et al., 1995, Report and Recommendations of the Panel to Assess the NIH Investment in Research on Gene Therapy.
Hamman et al., 2005, Biodrugs, vol. 19, No. 3, p. 165-177.
Acquati et al. “Tumor and Metastasis Suppression by the Human RNASET2 Gene”, Int. J. Oncol., 26(5): 1159-1168, 2005. Abstract.
Mastronicola et al. “Key Extracellular and Intracellular Steps in the Antitumor Action of Seminal Ribonuclease”, European Journal of Biochemistry, 230(1): 242-249, 1995.
Leland et al. “Cancer Chemotherapy—Ribonucleases to the Rescue”, Chemistry & Biology, 8: 405-413, 2001.
Roiz et al. “Stigmatic RNase in Self-Compatible Peach (Prunus Persica)”, Int. J. Plant. Sci. 156:(1): 37-41, 1995.
Deshpande et al. “Ribonucleases From T2 Family”, Critical Reviews in Microbiology, 28(2): 79-122, 2002.
Castro et al. “Gene Therapy for Parkinson's Disease: Recent Achievements and Remaining Challenges”, Histol. Histopathol., 16: 1225-1238, 2001.
Laemmli “Relevant Page on Gel Electrophoresis”, Nature, 227: 681, 1970.
Broothaerts et al. “Petunia Hybrida S-Proteins: Ribonuclease Activity and the Role of Their Glycan Side Chains in Self-Incompatibility”, Sex Plant Reprod., 4: 258-266, 1991.
Bradford “A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding”, Anal.Biochem. 72: 248-245, 1976.
Yokota et al. “Isolation and Characterization of Plant Myosin From Pollen Tubes of Lily”, Protoplasma, 177: 153-162, 1994.
Lin et al. “Characterization of the Mechanism of Cellular and Cell Free Protein Synthesis Inhibition by an Anti-Tumor Ribonuclease”, Biochem. Biophys. Res. Commun. 14, 204(1): 156-162, 1994.
Brown et al. “Barley Aleurone Layers Secrete a Nuclease in Response to Gibberellic Acid”, Plant Physiol. 82: 801-806, 1986.
Heslop-Harrison et al. “Dynamic Aspects of Apical Zonation in the Angiosperm Pollen Tube”, Sex. Plant Reprod., 3: 187-194, 1990.
Irie et al. “Site of Alkylation of the Major Ribonuclease From Aspergillus Saitoi With Iodoacetate”, J. Biochem., 99(3): 627-633, 1986.
Simm et al. “On the Interaction of Bovine Seminal Rnase With Actin In Vitro”, Eur. J. Biochem., 166: 49-54, 1987.
Kawata et al. “Amino-Acid Sequence of Ribonuclease T2 from Aspergillus Oryzae”, Eur. J. Biochem., 176: 683-697, 1988. Esp. P.688; Claims: 1-60, 15, 20.
Ohgi et al. “Expression of Rnase Rh from Rhizopus Niveus in Yeast and Characterization of the Secreted Proteins”, J. Biochem., 109: 776-785, esp. P.777, 1991. Esp. P.777; Claims: 21, 26.
Irie et al. “Structure-Function Relationships of Acid Ribonucleases: Lysosomal, Vacuolar and Periplasmic Enzymes”, Pharmacol. Ther., 81(2): 77-89, 1999. Esp. P.79; Claims: 15, 20.
Roiz et al. “Characterization of Aspergillus Niger B-1 RNase and Its Inhibitory Effect on Pollen Germination and Pollen Tube Growth in Selected Tree Fruit”, J. Amer. Soc. Hort. Sci., 125(1): 9-14, 2000. Esp. Abstract; Claims: 1, 6, 19.
Nomachi et al. “Purification and Some Properties of 2 Acid RNASE Fractions EC-3.1.27.1 EC-3.1.27.3 from the Mycelia of Aspergillus Niger”, J. General and Applied Microbiology, 26(6): 375-386, 1980. Claims: 1-60.
Hu et al. “Technology to Obtain Sustained Release Characteristics of Drugs After Delivered to the Colon”, J. Drug Target, 6(6): 439-448, 1999.
Ishibashi et al. “Evaluation of Colonic Absorbability of Drugs in Dogs Using a Novel Colon—Targeted Delivery Capsule (CTDC)”, J. Control Relaese, 59(3): 361-376, 1999.
Matsuda et al. “Effect of Food Intake on the Delivery of Fluorescein as a Model Drug in Colon Delivery Capsule After Oral Administration to Beagle Dogs”, J. Drug Target, 4(2): 59-67, 1996.
Takaya et al. “Development of a Colon Delivery Capsule and the Pharmacological Activity of Recombinant Human Granulocyte Colony-Stimulating Factor (RhG-CSF) in Beagle Dogs”,J. Pharm. Pharmacol., 47(6): 474-478, 1995. Abstract.
Tozaki et al. “Chitosan Capsules for Colon-Specific Drug Delivery: Improvement of Insulin Absorption From the Rat Colon”, J. Pharm. Sci., 86(9): 1016-1021, 1997. Abstract.
Tozaki et al. “Colon-Specific Delivery of R68070, A New Thromboxane Synthase Inhibitor, Using Chitosan Capsules: Therapeutic Effects Against 2,4,6-Trinitrobenzene Sulfonic Acid-Induced Ulcerative Colitis in Rats”, Life Sci., 64(13): 1155-1162, 1999. Abstract.
Hu et al. “An Angiogenin-Binding Protein from Endothelial Cells”, Proc. Natl. Acad. Sci., 88: 2227-2231, 1991.
Hu et al. “Actin is a Binding for Angiogenin”, Proc. Natl. Acad. Sci., 90: 1217-1221, 1993.
Kao et al. “A Small-Molecule Inhibitor of the Ribonucleolytic Activity of Human Angiogenin that Possesses Antitumor Activity”, Proc. Natl. Acad. Sci., 99: 10066-10071, 2002.
Eck et al. “Gene-Based Therapy”, Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9(Chap.5): 77-101, 1996.
Rudinger “Characteristics of the Amino Acids as Components of a Peptide Hormone Sequence”, University Park Press, Baltimore, p. 1-7, 1976.
Kaye et al. “A Single Amino Acid Substitution Results in a Retinoblastoma Protein Defective in Phosphorylation and Oncoprotein Binding”, Proc. Natl. Acad. Sci., 87: 6922-6926, 1990.
Skolnick et al. “From Genes to Protein Structure and Function: Novel Applications of Computational Approaches in the Genomic Era”, Trends in Biotech. (TIBTECH), 18: 34-39, 2000.
Kawata et al. “Identification of Two Essential Histidine Residues of RNASE T-2 from Aspergillus Oryzae”, Eur. J. Biochem., 187(1): 255-262, 1990. Claims: 1-60.
Roiz et al. “Stigmatic Rnase in Calamondin (Citrus Reticulata Var. Austera x Fortunella Sp.)”, Physiol. Plant., 94: 585-590, 1995.
Laccetti et al. “Seminal Ribonuclease Inhibits Tumor Growth and Reduces the Metastatic Potential of Lewis Lung Carcinoma”, Cancer Research, American Assoc. for Cancer Res, 54: 4523-4526, 1994. Claims: 1-60.
Trubia et al. “Mammalian Rh/T2/S-Glucoprotein Ribonuclease Family Genes: Cloning of a Human Member Located in in a Region of Chromosome 6 (6q27) Frequently Deleted in Human Malignancies”, Genomics, 42(2): 342-344, 1997: Claims: 1-60.
Examination Report Dated Nov. 20, 2006 From the Government of India, Patent Office Re.: Application No. IN/PCT/2002/441/CHE.
Requisitio
Roiz Levava
Schwartz Betty
Shoseyov Oded
Smirnoff Patricia
Chen Shin-Lin
Townsend and Townsend / and Crew LLP
Yissum Research Development Company of the Hebrew University of
LandOfFree
Methods of and compositions for inhibiting the proliferation... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of and compositions for inhibiting the proliferation..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of and compositions for inhibiting the proliferation... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4184637